Expression of ATP-binding cassette transporters B1 and C1 after severe traumatic brain injury in humans

Journal of Neurotrauma

Volumn 33, Issue 2, 2016, Pages 226-231

  Willyerd, F Anthony ^a,c   Empey, Philip E ^a,b   Philbrick, Ashley ^b   Ikonomovic, Milos D ^a   Puccio, Ava M ^a   Kochanek, Patrick M ^a   Okonkwo, David O ^a   Clark, Robert S B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

ABCB1; ABCC1; MDR1; MRP1; multidrug resistance protein; multidrug resistance associated protein; p glycoprotein

Indexed keywords

MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1;

ADULT; AGED; ARTICLE; BRAIN BLOOD VESSEL; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MIDDLE AGED; NERVE CELL; PROTEIN EXPRESSION; TRAUMATIC BRAIN INJURY; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT; ADOLESCENT; ALZHEIMER DISEASE; BRAIN CORTEX; BRAIN INJURY; METABOLISM; SEVERITY OF ILLNESS INDEX; TISSUE BANK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN INJURIES; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEINS; SEVERITY OF ILLNESS INDEX; TISSUE BANKS; YOUNG ADULT;

EID: 84954357440     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2015.3879     Document Type: Article

References (53)

1. Faul, M., Xu, L., Wald, M.M., and Coronado, V.G. (2010). Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006. Centers for Disease Control and Prevention: Atlanta
2. Gerberding, J.L., and Binder, S. (2003). Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem. Centers for Disease Control and Prevention: Atlanta
3. Hukkelhoven, C.W., Steyerberg, E.W., Rampen, A.J., Farace, E., Habbema, J.D., Marshall, L.F., Murray, G.D., and Maas, A.I. (2003). Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J. Neurosurg. 99, 666-673.
4. Arabi, Y.M., Haddad, S., Tamim, H.M., Al-Dawood, A., Al-Qahtani, S., Ferayan, A., Al-Abdulmughni, I., Al-Oweis, J., and Rugaan, A. (2010). Mortality reduction after implementing a clinical practice guidelines-based management protocol for severe traumatic brain injury. J. Crit. Care. 25, 190-195.
5. Brown, J.I., Baker, A.J., Konasiewicz, S.J., and Moulton, R.J. (1998). Clinical significance of CSF glutamate concentrations following severe traumatic brain injury in humans. J. Neurotrauma. 15, 253-263.
6. Eisenberg, H.M., Frankowski, R.F., Contant, C.F., Marshall, L.F., and Walker, M.D. (1988). High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J. Neurosurg. 69, 15-23.
7. Marshall, L.F., and Marshall, S.B. (1995). Pitfalls and advances from the international tirilazad trial in moderate and severe head injury. J. Neurotrauma. 12, 929-932.
8. Morris, G.F., Bullock, R., Marshall, S.B., Marmarou, A., Maas, A., and Marshall, L.F. (1999). Failure of the competitive N-methyl-Daspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J. Neurosurg. 91, 737-743.
9. Muizelaar, J.P., Kupiec, J.W., and Rapp, L.A. (1995). PEG-SOD after head injury. J. Neurosurg. 83, 942.
10. Murray, G.D., Teasdale, G.M., and Schmitz, H. (1996). Nimodipine in traumatic subarachnoid haemorrhage: a re-Analysis of the HIT I and HIT II trials. Acta Neurochir. (Wien) 138, 1163-1167.
11. Schwartz, M.L., Tator, C.H., Rowed, D.W., Reid, S.R., Meguro, K.,and Andrews, D.F. (1984). The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can. J. Neurol. Sci. 11, 434-440.
12. Teasdale, G., Bailey, I., Bell, A., Gray, J., Gullan, R., Heiskanan, O., Marks, P.V., Marsh, H., Mendelow, D.A., Murray, G. and et al. (1992) A randomized trial of nimodipine in severe head injury: HIT I. British/Finnish Co-operative Head Injury Trial Group. J. Neurotrauma 9 Suppl. 2, S545-S550.
13. Ward, J.D., Becker, D.P., Miller, J.D., Choi, S.C., Marmarou, A., Wood, C., Newlon, P.G., and Keenan, R. (1985). Failure of prophylactic barbiturate coma in the treatment of severe head injury. J. Neurosurg. 62, 383-388.
14. Wright, D.W., Yeatts, S.D., Silbergleit, R., Palesch, Y.Y., Hertzberg, V.S., Frankel, M., Goldstein, F.C., Caveney, A.F., Howlett-Smith, H., Bengelink, E.M., Manley, G.T., Merck, L.H., Janis, L.S., and Barsan, W.G. (2014). Very early administration of progesterone for acute traumatic brain injury. N. Engl. J. Med. 371, 2457-2466.
15. Potschka, H. (2010). Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach. Pharmacol. Ther. 125, 118-127.
16. Bendayan, R., Lee, G., and Bendayan, M. (2002). Functional expression and localization of P-glycoprotein at the blood brain barrier. Microsc. Res. Tech. 57, 365-380.
17. Begley, D.J. (2004). ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 10, 1295-1312.
18. Wijesuriya, H.C., Bullock, J.Y., Faull, R.L., Hladky, S.B., and Barrand, M.A. (2010). ABC efflux transporters in brain vasculature of Alzheimer's subjects. Brain Res, 1358, 228-238.
19. Sun, H., Dai, H., Shaik, N., and Elmquist, W.F. (2003). Drug efflux transporters in the CNS. Adv. Drug Deliv. Rev. 55, 83-105.
20. Hartz, A.M., and Bauer, B. (2011). ABC transporters in the CNS-An inventory. Curr. Pharm. Biotechnol. 12, 656-673.
21. Clark, R.S., Kochanek, P.M., Chen, M., Watkins, S.C., Marion, D.W., Chen, J., Hamilton, R.L., Loeffert, J.E., and Graham, S.H. (1999). Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J. 13, 813-821.
22. DeKosky, S.T., Abrahamson, E.E., Ciallella, J.R., Paljug, W.R., Wisniewski, S.R., Clark, R.S., and Ikonomovic, M.D. (2007). Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch. Neurol. 64, 541-544.
23. Ikonomovic, M.D., Uryu, K., Abrahamson, E.E., Ciallella, J.R., Trojanowski, J.Q., Lee, V.M., Clark, R.S., Marion, D.W., Wisniewski, S.R., and DeKosky, S.T. (2004). Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 190, 192-203.
24. Zhang, X., Alber, S., Watkins, S.C., Kochanek, P.M., Marion, D.W., Graham, S.H., and Clark, R.S. (2006). Proteolysis consistent with activation of caspase-7 after severe traumatic brain injury in humans. J. Neurotrauma. 23, 1583-1590.
25. Zhang, X., Graham, S.H., Kochanek, P.M.,Marion, D.W., Nathaniel, P.D., Watkins, S.C., and Clark, R.S. (2003). Caspase-8 expression and proteolysis in human brain after severe head injury. FASEB J. 17, 1367-1369.
26. Nies, A.T., Jedlitschky, G., Konig, J., Herold-Mende, C., Steiner, H.H., Schmitt, H.P., and Keppler, D. (2004). Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience. 129, 349-360.
27. Aronica, E., Gorter, J.A., Ramkema, M., Redeker, S., Ozbas-Gerceker, F., van Vliet, E.A., Scheffer, G.L., Scheper, R.J., van der Valk, P., Baayen, J.C., and Troost, D. (2004). Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia. 45, 441-451.
28. Daood, M., Tsai, C., Ahdab-Barmada, M., and Watchko, J.F. (2008). ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics. 39, 211-218.
29. Uchida, Y., Ohtsuki, S., Katsukura, Y., Ikeda, C., Suzuki, T., Kamiie, J., and Terasaki, T. (2011). Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J. Neurochem. 117, 333-345.
30. DeCory, H.H., Piech-Dumas, K.M., Sheu, S.S., Federoff, H.J., and Anders, M.W. (2001). Efflux of glutathione conjugate of monochlorobimane from striatal and cortical neurons. Drug Metab. Dispos. 29, 1256-1262.
31. Falcao, A.S., Bellarosa, C., Fernandes, A., Brito, M.A., Silva, R.F., Tiribelli, C., and Brites, D. (2007). Role of multidrug resistance-Associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin. Neuroscience. 144, 878-888.
32. Cousar, J.L., Conley, Y.P., Willyerd, F.A., Sarnaik, A.A., Puccio, A.M., Empey, P.E., Kochanek, P.M., Bell, M.J., Okonkwo, D.O., and Clark, R.S. (2013). Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury. Neurocrit. Care. 19, 192-198.
33. Bakos, E., and Homolya, L. (2007). Portrait of multifaceted transporter, the multidrug resistance-Associated protein 1 (MRP1/ABCC1). Pflugers Arch. 453, 621-641.
34. Bayir, H., Kagan, V.E., Tyurina, Y.Y., Tyurin, V., Ruppel, R.A., Adelson, P.D., Graham, S.H., Janesko, K., Clark, R.S., and Kochanek, P.M. (2002). Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Res. 51, 571-578.
35. Hammond, C.L., Marchan, R., Krance, S.M., and Ballatori, N. (2007). Glutathione export during apoptosis requires functional multidrug resistance-Associated proteins. J. Biol. Chem. 282, 14337-14347.
36. Lai, Y., Hickey, R.W., Chen, Y., Bayir, H., Sullivan, M.L., Chu, C.T., Kochanek, P.M., Dixon, C.E., Jenkins, L.W., Graham, S.H., Watkins, S.C., and Clark, R.S. (2008). Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J. Cereb. Blood Flow Metab. 28, 540-550.
37. Pandya, J.D., Readnower, R.D., Patel, S.P., Yonutas, H.M., Pauly, J.R., Goldstein, G.A., Rabchevsky, A.G., and Sullivan, P.G. (2014). Nacetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI. Exp. Neurol. 257, 106-113.
38. Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R.J., Carvalho, F., de Lourdes Bastos, M., and Remiao, F. (2015). Modulation of Pglycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol. Ther. 149, 1-123.
39. Cascorbi, I., Fluh, C., Remmler, C., Haenisch, S., Faltraco, F., Grumbt, M., Peters, M., Brenn, A., Thal, D.R., Warzok, R.W., and Vogelgesang, S. (2013). Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease. Pharmacogenomics. 14, 485-494.
40. Loscher, W., and Potschka, H. (2002). Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J. Pharmacol. Exp. Ther. 301, 7-14.
41. Sisodiya, S.M., Lin, W.R., Harding, B.N., Squier, M.V., and Thom, M. (2002). Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain. 125, 22-31.
42. Siddiqui, A., Kerb, R., Weale, M.E., Brinkmann, U., Smith, A., Goldstein, D.B., Wood, N.W., and Sisodiya, S.M. (2003). Association of multidrug resistance in epilepsy with a polymorphism in the drugtransporter gene ABCB1. N. Engl. J. Med. 348, 1442-1448.
43. Basic, S., Hajnsek, S., Bozina, N., Filipcic, I., Sporis, D., Mislov, D., and Posavec, A. (2008). The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood-brain barrier in patients with generalized epilepsy. Seizure. 17, 524-530.
44. Bournissen, F.G., Moretti, M.E., Juurlink, D.N., Koren, G., Walker, M., and Finkelstein, Y. (2009). Polymorphism of the MDR1/ABCB1 C3435T drug-Transporter and resistance to anticonvulsant drugs: a meta-Analysis. Epilepsia. 50, 898-903.
45. Gazzin, S., Strazielle, N., Schmitt, C., Fevre-Montange, M., Ostrow, J.D., Tiribelli, C., and Ghersi-Egea, J.F. (2008). Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J. Comp. Neurol. 510, 497-507.
46. Pop, V., Sorensen, D.W., Kamper, J.E., Ajao, D.O., Murphy, M.P., Head, E., Hartman, R.E., and Badaut, J. (2013). Early brain injury alters the blood-brain barrier phenotype in parallel with beta-Amyloid and cognitive changes in adulthood. J. Cereb. Blood Flow Metab. 33, 205-214.
47. Nuti, S.L., and Rao, U.S. (2002). Proteolytic cleavage of the linker region of the human P-glycoprotein modulates its ATPase function. J. Biol. Chem. 277, 29417-29423.
48. Ohkawa, K., Asakura, T., Takada, K., Sawai, T., Hashizume, Y., Okawa, Y., and Yanaihara, N. (1999). Calpain inhibitor causes accumulation of ubiquitinated P-glycoprotein at the cell surface: possible role of calpain in P-glycoprotein turnover. Int. J. Oncol. 15, 677-686.
49. Ren, X.Q., Furukawa, T., Nakajima, Y., Takahashi, H., Aoki, S., Sumizawa, T., Haraguchi, M., Kobayashi, M., Chijiiwa, K., and Akiyama, S. (2005). GSH inhibits trypsinization of the C-Terminal half of human MRP1. J. Biol. Chem. 280, 6231-6237.
50. Clark, R.S., Kochanek, P.M., Watkins, S.C., Chen, M., Dixon, C.E., Seidberg, N.A., Melick, J., Loeffert, J.E., Nathaniel, P.D., Jin, K.L., and Graham, S.H. (2000). Caspase-3 mediated neuronal death after traumatic brain injury in rats. J. Neurochem. 74, 740-753.
51. Kampfl, A., Posmantur, R.M., Zhao, X., Schmutzhard, E., Clifton, G.L., and Hayes, R.L. (1997). Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: implications for pathology and therapy: a review and update. J. Neurotrauma. 14, 121-134.
52. Wang, Y., Luo, W., and Reiser, G. (2008). Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell. Mol. Life Sci. 65, 237-252.
53. Clark, R.S., Bayir, H., Chu, C.T., Alber, S.M., Kochanek, P.M., and Watkins, S.C. (2008). Autophagy is increased in mice after traumatic brain injury and is detectable in human brain after trauma and critical illness. Autophagy. 4, 88-90.